Market Blog

Bullish sentiments for Ardelyx, Inc and Target Corporation

ARDX– Ardelyx, Inc is a clinical stage bio-pharmaceutical company which develops therapeutic drugs for the treatment of Gastro-Intestinal and Cardio – Renal diseases. ARDX was given a “Buy”rating from Ladenburg Thalmann, and may be bullish today. ARDX – Ardelyx, Inc. Fundamentals Previously closed at 7.77 Day's high 8.02 Day's low 7.41 P/E ratio NA EPS -0.76   Analysts opinion Out of the 4 wall street analysts covering the stock, all